OHSU in the news

Switching TNF inhibitors rare, delayed in AS despite inefficacy

Healio March 17, 2020
Atul Deodhar, M.D., reports 22% of patients with the chronic joint inflammation condition ankylosing spondylitis (AS) discontinue treatment with tumor necrosis factor (TNF) inhibitors after a year due to drug inefficacy or adverse events.

How OHSU is preparing for surge of coronavirus patients

Associated Press March 16, 2020
OHSU postpones elective and non-emergency procedures, clinical research to free up hospital capacity, personal protective equipment and health care workforce in advance of expected increases in positive COVID-19 cases.
See more stories